Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sannova is a premier contract research organization (CRO) that specializes in providing comprehensive bioanalytical services to pharmaceutical and biotechnology companies. Headquartered in Somerset, New Jersey, the company offers expertise in the analysis of small molecules, biologics, and biosimilars, supporting drug development from the preclinical phase through all stages of clinical trials. Their service portfolio includes pharmacokinetic (PK) and pharmacodynamic (PD) analysis, immunogenicity testing, and biomarker validation using advanced technologies such as LC-MS/MS and ligand binding assays. In early 2024, Sannova was acquired by SGS, a global leader in testing and certification, to strengthen SGS's bioanalytical capabilities in the North American market. The company maintains a strong reputation for regulatory compliance and high-quality data delivery in a GLP-compliant environment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sannova.